REGISTERED
on 30 Mar 2021
Last Applicant/ Owned by
601 Carlson Parkway, Suite 1050
Minnetonka
MN
55305
Serial Number
87341980 filed on 20th Feb 2017
Registration Number
6309150 registered on 30th Mar 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
M
Pharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes
First Use Date in General
24th Apr 2020
First Use Date in Commerce
24th Apr 2020
Mark Details
Serial Number
No 87341980
Mark Type
No Service/Collective Mark
Attorney Docket Number
No G40110
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.02 -
Plain single line circles
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Apr 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 16th Apr 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 16th Apr 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 30th Mar 2021 | REGISTERED-PRINCIPAL REGISTER |
| 24th Feb 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 23rd Feb 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th Feb 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 19th Feb 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 18th Feb 2021 | ASSIGNED TO LIE |
| 18th Nov 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |